These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7207646)

  • 1. Differential effects of potassium on the potency of different opioids in the mouse vas deferens.
    Wüster M; Schulz R
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):181-4. PubMed ID: 7207646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly specific opiate receptors for dynorphin-(1-13) in the mouse vas deferens.
    Wüster M; Schulz R; Herz A
    Eur J Pharmacol; 1980 Mar; 62(2-3):235-6. PubMed ID: 6103811
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of current strength on inhibitory responses of the mouse vas deferens to methionine- and leucine-enkephalin.
    Hart SL; Kitchen I; Waddell PR
    Br J Pharmacol; 1979 Jul; 66(3):361-3. PubMed ID: 526704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oxytocin on the isolated vas deferens of the rat.
    Beneit JV; Hidalgo A; Tamargo JL
    Br J Pharmacol; 1980 Jul; 69(3):379-82. PubMed ID: 7397448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The choice of opiate receptor subtype by neo-endorphins.
    Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
    Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate agonists inhibit noradrenaline release via opiate B-receptors and N-cyclopropylmethylnorazidomorphine (CAM) blocks electrically evoked contractions via histamine in the mouse vas deferens.
    Knoll J; Kerecsen L; Somogyi GT; Kovács A
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):52-65. PubMed ID: 6266359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choice of opioid receptor subtype in isolated preparations by dynorphins.
    Oka T; Aoki K; Kajiwara M
    Life Sci; 1983; 33 Suppl 1():311-4. PubMed ID: 6141492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The direction of opiodid agonists towards mu-, delta- and epsilon-receptors in the vas deferens of the mouse and the rat.
    Wüster M; Schulz R; Herz A
    Life Sci; 1980 Jul; 27(2):163-70. PubMed ID: 6249997
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of enkephalin and substance P on sympathetic nerve transmission in mouse vas deferens.
    Segawa T; Murakami H; Ogawa H; Yajima H
    Jpn J Pharmacol; 1978 Feb; 28(1):13-9. PubMed ID: 206750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of delta-opioid receptors in the hamster vas deferens.
    Sheehan MJ; Hayes AG; Tyers MB
    Eur J Pharmacol; 1986 Oct; 130(1-2):57-64. PubMed ID: 3023115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of enkephalin and endorphin analogs on receptors in the mouse vas deferens.
    Britton DR; Fertel R; Coy DH; Kastin AJ
    Biochem Pharmacol; 1978; 27(18):2275-7. PubMed ID: 215153
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
    Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
    Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
    Huidobro-Toro JP; Caturay EM; Ling N; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):262-9. PubMed ID: 6123591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of somatostatin and enkephalins on the guinea pig ileum and the rat vas deferens.
    Jhamandas K; Elliott J
    Can J Physiol Pharmacol; 1980 Nov; 58(11):1389-92. PubMed ID: 6111385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM; Chavkin C
    Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
    [No Abstract]   [Full Text] [Related]  

  • 17. Rat vas deferens: a specific bioassay for endogenous opioid peptides.
    Lemaire S; Magnan J; Regoli D
    Br J Pharmacol; 1978 Nov; 64(3):327-9. PubMed ID: 719230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype dependent response of morphine and methionine-enkephalin on the electrically induced contractions of the mouse vas deferens.
    Berti F; Bruno F; Omini C; Racagni G
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 305(1):5-8. PubMed ID: 723970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific H+/K(+)-ATPase inhibitors decreased contractile responses of isolated rat vas deferens.
    Yenişehirli A; Onur R
    Pharmacol Res; 2006 Dec; 54(6):397-405. PubMed ID: 16949299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mu, kappa and delta properties of various opioid agonists.
    Takemori AE; Ikeda M; Portoghese PS
    Eur J Pharmacol; 1986 Apr; 123(3):357-61. PubMed ID: 3013652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.